Fibroblast growth factor 10 ameliorates neurodegeneration in mouse and cellular models of Alzheimer's disease via reducing tau hyperphosphorylation and neuronal apoptosis. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.